Fibrin-Factor XIII complex (Fibrin-FXIII complex)

The Fibrin-Factor XIII complex is a stabilized protein network that forms the structural backbone of a blood clot. It is generated when thrombin converts soluble fibrinogen into fibrin monomers, which then polymerize and are subsequently cross-linked by activated Factor XIII (FXIIIa), a transglutaminase (Muszbek et al., 2011, Physiol Rev). This cross-linking process involves the formation of covalent bonds between specific lysine and glutamine residues in the fibrin chains, providing the clot with essential mechanical stability and resistance to premature enzymatic degradation by plasmin (Ariëns et al., 2002, Thromb Haemost). Biologically, this complex is vital for effective hemostasis and serves as a scaffold for wound healing and tissue repair. However, the persistence of this complex in the vasculature leads to pathological conditions such as deep vein thrombosis, pulmonary embolism, and arterial occlusion (Schroeder & Kohler, 2013, Semin Thromb Hemost). Pharmacological intervention typically involves thrombolytic agents like Alteplase, which promote the degradation of the fibrin matrix, or the use of Factor XIII concentrates to treat deficiencies that prevent complex formation. Emerging research also explores Factor XIIIa inhibitors as a means to create "labilized" clots that are more easily cleared by the body's natural fibrinolytic system (NCBI, 2023).

Other names

Cross-linked fibrinFibrin-FXIIIa complexStabilized fibrin meshInsoluble fibrinEndogenous fibrin/Factor XIII complex

Fibrinolysis via plasminogen activation to plasmin; Covalent cross-linking of fibrin monomers by transglutaminase activity